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A B S T R A C T
The strength of echocardiography has always been in its capacity for convenient real-
time imaging, its rapid acquisition and analysis capabilities. Echocardiography has 
been one of the most rapidly expanding fields in modern cardiology and has seen un-
precedented advances over the last 20 years. One of the most significant advances in 
this area is that of three-dimensional echocardiography (3DE). 3DE is not a new idea 
or indeed a new technique; it has been a research tool in various guises for many years. 
New transducer technology coupled with advances in computing have transformed 
this modality from a labour-intensive imaging protocol to a real-time imaging that 
can be rapidly analysed online. Continued improvements in image acquisition and 
quantification help integrate this into clinical practice and have brought it to the cusp 
of widespread clinical acceptance.
Many different 3DE techniques have been developed and validated. By obviating the 
need for geometric assumptions, transthoracic 3DE allows accurate assessment of 
left ventricular mass, volumes and function as well as right ventricular and left atrial 
volumes. Furthermore, the advent of real-time 3D trans-esophageal echo has found 
a clear role in assessment of valvular disease as well as guidance of percutaneous pro-
cedures including trans-septal puncture, atrial and ventricular septal defect closure 
device deployment, trans-catheter aortic valve implant and percutaneous mitral valve 
repair. In conclusion, for some time, 3DE has had a host of proven applications within 
cardiology, which are rapidly becoming a clinical standard.
I N T R O D U C T I O N
The strength of echocardiography has always been in its capacity for convenient 
real-time imaging, its rapid acquisition and analysis capabilities. Echocardiography 
has been on of the most rapidly expanding fields in modern cardiology and has seen 
unprecedented advances over the last 20 years.
One of the most significant advances in this area is that of three-dimensional 
echocardiography (3DE). 3DE is not a new idea or indeed a new technique; it has been 
a research tool in various guises for many years. New transducer technology coupled 
with advances in computing have transformed this modality from a labour-intensive 
imaging protocol to a real-time imaging that can be rapidly analysed online. Continued 
improvements in image acquisition and quantification help integrate this into clinical 
practice and have brought it to the cusp of widespread clinical acceptance.
Many different 3DE techniques have been developed and validated. By obviating 
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ing trans-septal puncture, atrial and ventricular septal defect 
closure device deployment, trans-catheter aortic valve implant 
(TAVI) and percutaneous mitral valve repair (PMVR).
T R A N S T H O R A C I C  3 D  E C H O
By eliminating the impact of geometric assumptions and 
off-axis acquisitions, 3DE provides a much more accurate 
assessment of left ventricular (LV) volumes and mass. The 
impact of long axis errors that occur with foreshortening in 
2D echo was demonstrated by Mor-Avi et al,1 who compared 
2DE, 3DE and cardiac magnetic resonance imaging (CMR) 
for assessment of LV mass. For this study, an accurate 4-cham-
ber and 2-chamber view were extracted from the 3D dataset 
and quantification was based on modified biplane Simpson’s 
method, comparable to standard 2DE techniques. There was 
excellent correlation between 3DE and CMR (r = 0.9 for 3DE, 
vs. 0.79 for 2DE). A notable finding in this study was that LV 
length was significantly lower in 2D acquisitions, implying that 
foreshortening in 2D acquisitions was a significant source of 
error when compared to 3DE and CMR. Similar observations 
were made by Pouleur et al in 83 patients with and without 
wall motion abnormalities.2
Incorporating 3DE for LV quantification may have an 
impact on clinical decision making. In a study by Hare et al,3 
220 unselected patients were examined and the impact on 
FIGURE 1. 3D imaging offers superior morphological assess-
ment. A tricuspid aortic valve with mildly thickened cusps (top 
row) and a functionally bicuspid valve (bottom row).
FIGURE 2. 3D quantification of LV mass: 4- and 2-chamber 
views are extracted from the data set to provide more accurate 
volume and mass measurements by eliminating long axis errors. 
LV= left ventricle.
FIGURE 3. Surgeon’s view of an obstructed bileaflet MV pros-
thesis. Pannus can be seen at the anterior hinge point. MV = 
mitral valve.
the need for geometric assumptions, transthoracic 3DE allows 
accurate assessment of left ventricular mass, volumes and 
function as well as right ventricular and left atrial volumes. 
Furthermore, the advent of real-time 3D trans-esophageal 
echo (3D TEE) has found a clear role in assessment of valvular 
disease as well as guidance of percutaneous procedures includ-
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decision making was based on 4 measurement thresholds: 
1) LV end-systolic volume (LVESV) >50 ml/m2 (indication 
for surgery in mitral regurgitation), 2) LVESV >30 ml/m2 
(prognosis post myocardial infarction), 3) LV ejection frac-
tion (LVEF) <35% (indication for implantable defibrillator 
therapy) and 4) LVEF <40% (initiation of heart failure ther-
apy). The investigators found that in this unselected group of 
patients, 3DE was feasible in 83% and that 3D acquisition and 
quantification added 5.2 minutes to the routine examination. 
More importantly, 3DE would have had a significant impact 
on decision making, suggesting a different outcome in up to 
18% compared to 2DE.
As with traditional echo, 3DE can be used with micro-
bubble contrast for left ventricular opacification to optimize 
endocardial border definition. More recently a low mechanical 
index contrast imaging has been added to the arsenal of 3D 
modalities, opening the possibility to assess myocardial per-
fusion in 3D - this however is still in the domain of research.
3DE may also be used for quantification of LV mechanical 
dyssynchrony.4-6 By dividing the global LV volume into sub-
volumes corresponding to the standard myocardial segments, 
it is possible to derive time-volume curves for each segment 
and thereby a timing of regional contraction. Several groups 
have validated the standard deviation of these timings (systolic 
FIGURE 5. Top row: A patent foramen ovale before and after 
percutaneous occlusion with an Amplatzer device. Lower row: 
P2 prolapse seen from surgeon’s view in real-time 3D (left) and 
with parametric display (right).
FIGURE 4. 3D regional quantification: Time-volume curves in a normal patient (left) show well synchronized regional contractions 
as all curves reach their minimum at the same time. A patient with severe LV dysfunction and dyssynchrony (right) displays wide 
dispersion of times to minimum regional volumes, or peak regional contraction. LV = left ventricle.
FIGURE 6. Deployment of Mitraclip device for percutaneous 
mitral repair, resulting in a double orifice valve.
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dyssynchrony index) in patients with heart failure undergoing 
cardiac resynchronization therapy. Single center data suggest 
that this parameter may be more accurate that traditional 2DE 
and tissue Doppler imaging methods for selecting patients, but 
multi-center trials are awaited.
T R A N S E S O P H A G E A L  3 D  E C H O
One of the most important advances on the 3DE platform 
was the addition of real-time 3D trans-esophageal echo. The 
3DE probe, like its transthoracic equivalent, hosts a matrix ar-
ray that allows acquisition high resolution 3D volumes without 
compromising the 2D imaging quality. This has made 3D TEE 
indispensable for detailed mitral valve (MV) assessment as 
well as guidance of percutaneous procedures.7-13
3D TEE easily provides a “surgeon’s view” of the mitral 
valve so that mental reconstruction of MV geometry is no 
longer required as the observer can observe all scallops si-
multaneously. The ability to derive 2D views from any part 
of the MV means that specific imaging of both commissures 
and all scallops is simplified and anatomically accurate. In 
addition, there are a number of software tools that allow 
accurate quantification of MV annular geometry as well as 
leaflet characteristics such as tenting and prolapse height 
and volume.
In a similar manner the LV outflow tract, aortic valve and 
ascending aorta can be viewed by any angle in real-time which 
is especially useful in TAVI. However, where 3D TEE is truly 
indispensable is in deployment of mitral clip for PMVR. With 
2D TEE, multiple views are required to guide the trans-septal 
puncture required for this procedure and to guide deployment 
of the mitral clip, whereas this is a simple matter in 3D TEE, 
particularly if more than 1 clips are used.
S U M M A R Y
For some time, 3DE has had a host of proven applica-
tions within cardiology, which are rapidly becoming a clinical 
standard.4-15 As the focus of medical management shifts from 
treatment to prevention, serial noninvasive measurements and 
detection of minute changes will become increasingly impor-
tant. There is already a growing requirement to detect small 
changes in LV mass, volume, and function in several clinical 
situations. For this application, we need rapid, accurate, safe, 
reliable, and reproducible techniques that are convenient for 
patients and practitioners. 3DE has been proven capable in 
many of these areas, and it will undoubtedly prove itself in 
the remainder.
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